Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Natpara Extension Study in Hypoparathyroidism
NCT03364738Phase 3Terminated
- Sponsor
- Takeda
- Start
- Sep 2018
- Primary completion
- Apr 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 4
01
Overview
A Phase 3 trial of parathyroid hormone 1-84 in hypoparathyroidism, sponsored by Takeda. Started Sep 2018; status: terminated.
02
Drugs
parathyroid hormone 1-84
03
Conditions
hypoparathyroidism
Beyond the preview
Go deeper on NCT03364738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03364738.